156 related articles for article (PubMed ID: 26401577)
1. POTASSIUM CITRATE DECREASES BONE RESORPTION IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA: A RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL.
Gregory NS; Kumar R; Stein EM; Alexander E; Christos P; Bockman RS; Rodman JS
Endocr Pract; 2015 Dec; 21(12):1380-6. PubMed ID: 26401577
[TBL] [Abstract][Full Text] [Related]
2. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
3. Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial.
Macdonald HM; Black AJ; Aucott L; Duthie G; Duthie S; Sandison R; Hardcastle AC; Lanham New SA; Fraser WD; Reid DM
Am J Clin Nutr; 2008 Aug; 88(2):465-74. PubMed ID: 18689384
[TBL] [Abstract][Full Text] [Related]
4. Potassium Citrate Supplementation Decreases the Biochemical Markers of Bone Loss in a Group of Osteopenic Women: The Results of a Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Granchi D; Caudarella R; Ripamonti C; Spinnato P; Bazzocchi A; Massa A; Baldini N
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30213095
[TBL] [Abstract][Full Text] [Related]
5. Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study.
Ishibashi H; Crittenden DB; Miyauchi A; Libanati C; Maddox J; Fan M; Chen L; Grauer A
Bone; 2017 Oct; 103():209-215. PubMed ID: 28687496
[TBL] [Abstract][Full Text] [Related]
6. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
[TBL] [Abstract][Full Text] [Related]
7. The effect of Cissus quadrangularis L. on delaying bone loss in postmenopausal women with osteopenia: A randomized placebo-controlled trial.
Benjawan S; Nimitphong H; Tragulpiankit P; Musigavong O; Prathanturarug S; Pathomwichaiwat T
Phytomedicine; 2022 Jul; 101():154115. PubMed ID: 35523116
[TBL] [Abstract][Full Text] [Related]
8. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
Cheung AM; Tile L; Lee Y; Tomlinson G; Hawker G; Scher J; Hu H; Vieth R; Thompson L; Jamal S; Josse R
PLoS Med; 2008 Oct; 5(10):e196. PubMed ID: 18922041
[TBL] [Abstract][Full Text] [Related]
9. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
Rønn SH; Harsløf T; Oei L; Pedersen SB; Langdahl BL
Osteoporos Int; 2021 Jan; 32(1):185-191. PubMed ID: 33030563
[TBL] [Abstract][Full Text] [Related]
10. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
[TBL] [Abstract][Full Text] [Related]
11. Partial neutralization of the acidogenic Western diet with potassium citrate increases bone mass in postmenopausal women with osteopenia.
Jehle S; Zanetti A; Muser J; Hulter HN; Krapf R
J Am Soc Nephrol; 2006 Nov; 17(11):3213-22. PubMed ID: 17035614
[TBL] [Abstract][Full Text] [Related]
12. Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 study.
Langdahl B; Binkley N; Bone H; Gilchrist N; Resch H; Rodriguez Portales J; Denker A; Lombardi A; Le Bailly De Tilleghem C; Dasilva C; Rosenberg E; Leung A
J Bone Miner Res; 2012 Nov; 27(11):2251-8. PubMed ID: 22777865
[TBL] [Abstract][Full Text] [Related]
13. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin D therapy on bone turnover markers in postmenopausal women with osteoporosis and osteopenia.
Tanzy ME; Camacho PM
Endocr Pract; 2011; 17(6):873-9. PubMed ID: 21550960
[TBL] [Abstract][Full Text] [Related]
15. Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
Bonnick S; De Villiers T; Odio A; Palacios S; Chapurlat R; DaSilva C; Scott BB; Le Bailly De Tilleghem C; Leung AT; Gurner D
J Clin Endocrinol Metab; 2013 Dec; 98(12):4727-35. PubMed ID: 24064689
[TBL] [Abstract][Full Text] [Related]
16. Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial.
Grey A; Bolland M; Wong S; Horne A; Gamble G; Reid IR
J Clin Endocrinol Metab; 2012 Jan; 97(1):286-92. PubMed ID: 22072741
[TBL] [Abstract][Full Text] [Related]
17. Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trial.
Grey A; Bolland M; Mihov B; Wong S; Horne A; Gamble G; Reid IR
J Bone Miner Res; 2014 Jan; 29(1):166-72. PubMed ID: 23761303
[TBL] [Abstract][Full Text] [Related]
18. The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial.
DeLuca HF; Bedale W; Binkley N; Gallagher JC; Bolognese M; Peacock M; Aloia J; Clagett-Dame M; Plum L
J Bone Miner Res; 2011 Mar; 26(3):538-45. PubMed ID: 20890933
[TBL] [Abstract][Full Text] [Related]
19. Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial.
Shen CL; Yang S; Tomison MD; Romero AW; Felton CK; Mo H
Osteoporos Int; 2018 Apr; 29(4):881-891. PubMed ID: 29330573
[TBL] [Abstract][Full Text] [Related]
20. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
Bone HG; Bolognese MA; Yuen CK; Kendler DL; Wang H; Liu Y; San Martin J
J Clin Endocrinol Metab; 2008 Jun; 93(6):2149-57. PubMed ID: 18381571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
